00.00, Monday 21 April 2008
Sir Andrew Witty HonFMedSci, CEO Designate, GlaxoSmithKline
The UK pharmaceutical industry - what does the future hold?
How is the pharmaceutical industry likely to evolve over the next ten years?? What will be the key impacts in research, development, and commercialisation? How can industry, Government and healthcare providers work together more effectively to support innovation, deliver value, and improve health outcomes for UK patients.